Can a 4-Minute chat rival a Dietitian's hour for heart health?
NCT ID NCT05772325
First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time
Summary
This study tests whether a short, standardized 4-minute heart-healthy talk is as effective as a full 60-minute personalized session with a dietitian for lowering LDL cholesterol and improving diet. Participants are adults aged 30–80 with rheumatoid arthritis, psoriatic arthritis, or spondyloarthritis who have an elevated risk of heart disease. The goal is to see if a quick, easy approach can help manage heart disease risk in people with inflammatory joint conditions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- dietary counseling
- What this could lead to
- If it works, this could show that simple, brief dietary advice is as effective as personalized counseling for improving heart health in people with inflammatory joint disease.
- What could go wrong
- This is a small study with only 70 participants, so results may not apply to everyone. Dietary changes can be hard to maintain, and the brief advice may not be enough to produce lasting improvements.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANKYLOSING SPONDYLITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Diakonhjemmet Hospital
Oslo, 0370, Norway
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A single blood test may reveal whether a gene tied to transplant outcomes influences psoriatic arthritis risk.
- Blood test could end guesswork in rheumatoid arthritis treatment
- Experimental biologic CND319 takes first steps toward taming autoimmune diseases
- Could cord cell secretions ease arthritis pain?
- New antibody aims to calm ankylosing spondylitis
- Which RA drug works best after the first one fails? a major trial aims to find out